SEC Comment Letter 0000000000-24-002399 to Viveon Health Acquisition Corp. (CIK 0001823857)
Viveon Health Acquisition Corp. (CIK 0001823857)
Date: March 4, 2024 · CIK: 0001823857 · Accession: 0000000000-24-002399
AI Filing Summary & Sentiment
File numbers found in text: 001-39827
Letter
United States securities and exchange commission logo March 4, 2024 Jagi Gill, Ph.D. Chief Executive Officer and Chairman of the Board Viveon Health Acquisition Corp. 3480 Peachtree Road NE 2nd Floor, Suite #112 Atlanta, GA 30326 Re:Viveon Health Acquisition Corp. Preliminary Proxy Statement on Schedule 14A Filed February 23, 2024 File No. 001-39827 Dear Jagi Gill: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Tahra Wright, Esq.
Show Raw Text
United States securities and exchange commission logo
March 4, 2024
Jagi Gill, Ph.D.
Chief Executive Officer and Chairman of the Board
Viveon Health Acquisition Corp.
3480 Peachtree Road NE 2nd Floor, Suite #112
Atlanta, GA 30326
Re:Viveon Health Acquisition Corp.
Preliminary Proxy Statement on Schedule 14A
Filed February 23, 2024
File No. 001-39827
Dear Jagi Gill:
We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Tahra Wright, Esq.